Pharma’s Digital Directive: Not If, But How

Data science and data analytics offer operational advantages throughout large organizations. And the pharma should approach digital technology pragmatically, first applying the tools to what it already does.

IV1810_Data_351572294_1200.jpg
Embracing digital technology, partnering for success • Source: Shutterstock

Digital technology, which includes the use of machine learning algorithms around large data sets and real-world data as well as digital measurement tools for collecting a wide swath of data in real time, has potential for impacting many parts of the pharma value chain. These methods can reduce time and cost to market through digitizing clinical trial operations and manufacturing; improve the understanding of how products perform in the real-world; and make products more competitive by improving patient outcomes through the use of a digital drug or companion digital solution.

“It will probably change every aspect of research and development,” says Mathai Mammen, MD, PhD, global head of R&D for...

More from Innovation

More from In Vivo

Deals In Depth: June 2025

 
• By 

Five $1bn+ alliances were penned in June, and four exceeded $2bn.

Global Pharma Interest In Korea Undeterred Despite Political Roller Coaster

 
• By 

Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.

Podcast: Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

 
• By 

Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.